Aviva extends cancer cover to include non-NHS drugs


Aviva has overhauled its cancer coverage for both individual and group private medical insurance (PMI) schemes.

Its new regime includes the removal of previous benefit limits for some cancer drugs, bone related treatments and scans and rehabilitation. The provider has also pledged to cover cancer treatments recommended by medical specialists in full, while following cancer treatment, aftercare benefits including consultations with dieticians and help with the costs of wigs and external prostheses are included. Treatment cover now includes chemotherapy, radiotherapy and targeted therapies such as Herceptin and Avastin, as well as cover for unlicensed drugs not readily available from the NHS. ...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes



Already a Professional Adviser member?


More on Individual

Bupa launches new patient helpline

Bupa has launched Bupa Anytime HealthLine, a helpline providing 24 hour, unlimited medical advice and information from a team of GPs and nurses.

clock 24 January 2012 •

Freedom Healthnet widens age limit

Freedom Healthnet has upped the age limit for clients wishing to purchase its private medical insurance (PMI) plan.

clock 16 January 2012 •

Brokers approve cancer cover moves

Medical insurance brokers have applauded moves by private medical insurance (PMI) providers to remove the limits on cancer coverage for many standard polices.

clock 10 January 2012 •